Discover how scientists engineered goldenberry plants to grow 35% shorter than usual, making them suitable for large-scale ...

Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...

Now, it’s worth noting Stock Advisor’s total average return is 991% — a market-crushing outperformance compared to 195 % for ...

Despite a challenging CASGEVY launch, high cash burn, and an almost 10% YTD share count growth, CRISPR’s pipeline breadth and ...

Casgevy, now a "national priority" drug, helped kids with sickle cell and thalassemia, results which may help toward a label ...

Goldenberries taste like a cross between pineapple and mango, pack the nutritional punch of a superfood, and are increasingly ...

One of the practical applications of thinking long-term is to buy and hold exceptional stocks with strong growth prospects. Here are three brilliant growth stocks to buy now and hold for the long term ...

Dyadic International Inc (NASDAQ:DYAI) has successfully transitioned from a platform-centric R&D organization to a commercially focused biotechnology company. The company achieved its first commercial ...

Programmable CRISPR tools are turning stem cell biology into something closer to software engineering, shrinking ...

Scientists grew a microscopic fungus into a more efficient — and meat-like — edible protein by tweaking just two genes with ...

The global pest control industry is steering towards a whopping $32.8 billion valuation by 2028, growing at a compound annual ...